Particle News: Latest Marty Makary news

11 ARTICLES

2d ago

FDA Reinstates Dr. Vinay Prasad as Biologics Chief Less Than Two Weeks After Resignation

HHS confirms he will lead vaccine and gene therapy reviews following pressure from Commissioner Marty Makary

16 ARTICLES

2mo ago

FDA Advances Plan to Remove Ingestible Fluoride Supplements for Children

7 ARTICLES

2mo ago

HHS to End Routine COVID-19 Vaccine Recommendations for Children and Pregnant People

4 ARTICLES

3mo ago

FDA Demands New Trials for Novavax COVID Vaccine, Raising Concerns Over Fall Booster Rollouts

7 ARTICLES

last mo.

FDA Chief Criticizes Medical Establishment, Advocates Lifestyle Changes for Health

10 ARTICLES

4d ago

U.S. Regulators Move to Classify Potent Kratom Derivative as Schedule I Opioid

7 ARTICLES

3d ago

HHS and FDA Move to Classify Potent Kratom Derivative as Schedule I

6 ARTICLES

3mo ago

New Study Reveals Abortion Pill Complication Rate 22 Times Higher Than FDA Estimate

4 ARTICLES

3mo ago

HHS Secretary RFK Jr. Weighs Removing COVID-19 Vaccine From Childhood Schedule

4 ARTICLES

5mo ago

FDA Chief Counsel Resigns Days After Appointment Following Political Pushback

Particle.news

Marty Makary

United States Commissioner of Food and Drugs

FDA Reinstates Dr. Vinay Prasad as Biologics Chief Less Than Two Weeks After Resignation

FDA Advances Plan to Remove Ingestible Fluoride Supplements for Children

HHS to End Routine COVID-19 Vaccine Recommendations for Children and Pregnant People

FDA Demands New Trials for Novavax COVID Vaccine, Raising Concerns Over Fall Booster Rollouts

More Than 10 Major Food Companies Pledge to Phase Out Synthetic Dyes

Kennedy Advances MAHA Health Overhaul Despite Report Critiques

U.S. Ramps Up Seizures of Hidden Chinese Vapes Targeting Teens

Marty Makary Faces Scrutiny in Confirmation Hearing for FDA Leadership

Major Ice Cream Producers to Eliminate Synthetic Dyes by 2027

FDA Commissioner Pledges Safety Review of Abortion Pill Mifepristone

Never miss stories about

Marty Makary

FDA Publishes Over 200 Complete Response Letters for 2020–24 Drug Applications

FDA Chief Criticizes Medical Establishment, Advocates Lifestyle Changes for Health

U.S. Regulators Move to Classify Potent Kratom Derivative as Schedule I Opioid

HHS and FDA Move to Classify Potent Kratom Derivative as Schedule I

New Study Reveals Abortion Pill Complication Rate 22 Times Higher Than FDA Estimate

HHS Secretary RFK Jr. Weighs Removing COVID-19 Vaccine From Childhood Schedule

FDA Chief Counsel Resigns Days After Appointment Following Political Pushback

Never miss stories about

Marty Makary